BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26017010)

  • 1. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
    Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
    Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
    Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
    Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
    Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
    Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
    Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
    Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
    Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
    Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
    Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
    Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease and patient characteristics in NP-C patients: findings from an international disease registry.
    Patterson MC; Mengel E; Wijburg FA; Muller A; Schwierin B; Drevon H; Vanier MT; Pineda M
    Orphanet J Rare Dis; 2013 Jan; 8():12. PubMed ID: 23324478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
    J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
    Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
    Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
    Pérez-Poyato MS; Gordo MM; Marfa MP
    Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.
    Fecarotta S; Romano A; Della Casa R; Del Giudice E; Bruschini D; Mansi G; Bembi B; Dardis A; Fiumara A; Di Rocco M; Uziel G; Ardissone A; Roccatello D; Alpa M; Bertini E; D'Amico A; Dionisi-Vici C; Deodato F; Caviglia S; Federico A; Palmeri S; Gabrielli O; Santoro L; Filla A; Russo C; Parenti G; Andria G
    Orphanet J Rare Dis; 2015 Feb; 10():22. PubMed ID: 25888393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.
    Patterson MC; Vecchio D; Prady H; Abel L; Wraith JE
    Lancet Neurol; 2007 Sep; 6(9):765-72. PubMed ID: 17689147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
    Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
    J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
    Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
    J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.
    Pineda M; Perez-Poyato MS; O'Callaghan M; Vilaseca MA; Pocovi M; Domingo R; Portal LR; Pérez AV; Temudo T; Gaspar A; Peñas JJ; Roldán S; Fumero LM; de la Barca OB; Silva MT; Macías-Vidal J; Coll MJ
    Mol Genet Metab; 2010 Apr; 99(4):358-66. PubMed ID: 20056559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
    Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
    JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR).
    Bolton SC; Soran V; Marfa MP; Imrie J; Gissen P; Jahnova H; Sharma R; Jones S; Santra S; Crushell E; Stampfer M; Coll MJ; Dawson C; Mathieson T; Green J; Dardis A; Bembi B; Patterson MC; Vanier MT; Geberhiwot T
    Orphanet J Rare Dis; 2022 Feb; 17(1):51. PubMed ID: 35164809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early miglustat therapy in infantile Niemann-Pick disease type C.
    Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
    Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.